If you want different results, do not do the same things

Albert Einstein

Nanokide Therapeutics is a biotechnology company focused on the development of novel antimetastatic solutions based on the combination of nanotechnology and microRNA and mRNA.

Our nanosystems is a flexible, non-toxic and easy to produce formulation that combined with microRNA and mRNA sequences offer a perfect platform for anticancer drugs development.

Isabel Rial

CEO and Founder

PhD in Pharmacy / Researcher

Iker Badiola

Founder

PhD in Biology / Assistant professor in UPV/EHU

Majid Khatib

Founder

PhD in Biology/ INSERM

The core of our technology is the combination of a flexible nanosystem with microRNA and mRNA therapy against cancer.
The nanosystem developed by Nanokide is based on sorbitan ester.
13/07/2022

NIH grants Nanokide

The NCL has selected our technology Span-based nanoparticles loaded with miR-20a for the preclinical development program

Read More
11/07/2022

Toribio Echevarria Awards

Nanokide has been awarded as a finalist in the Business Ideas/Projects section of the Toribio Echevarria 2022 awards.

Read More
16/09/2022

Cantábrico Excelente Awards

Nanokide Therapeutics has been nominated in the category of best R+D+i company in the VI edition of the Cantabrian Excellent Awards.

Read More
20/07/2022

"Our nanoparticle blocks tumor growth"

Interview in the newspaper Berria

Read More

Finalist Toribio Echevarria Awards 2022

Nominated Cantábrico de Excelencia Award 2022

Nominated DEIA VODAFONE INNOVATION Award 2022

  • Ed. Rectorado – Planta baja Campus de Bizkaia. Sarriena s/n. 48940 Leioa

Videos, images and gifs made by Rosario García Hernández